TABLE 1.
Fragment | Domain(s) | FADa | Association stateb | ATP-ADP bindingc | NifA interactiond | GlnK interactione | ADP responsef | Nitrogen response
|
Oxygen response
|
||
---|---|---|---|---|---|---|---|---|---|---|---|
In vivog | In vitroh | In vivog | In vitroi | ||||||||
Wild-type NifL | PAS1, PAS2, H, GHKL | + | Tetramer | + | + | + | + | + | + | + | + |
1-140 | PAS1 | + | Tetramer | NDj | ND | ND | ND | ND | ND | ND | ND |
1-284 | PAS1, PAS2 | + | Tetramer | − | − | − | − | ND | − | ND | − |
147-519 | PAS2, H, GHKL | − | Mostly dimer | + | + | + | + | + | + | − | − |
360-519 | GHKL | − | Monomer | + | + | + | + | ND | − | ND | − |
Derived from limited proteolysis data (93).
Complex formation measured by coaffinity chromatography in the presence of Mg-ADP (69).
Ability to bind GlnK in the presence of 2-oxoglutarate and ATP, determined by pull down assays and surface plasmon resonance (60).
Ability to inhibit open promoter complex formation by NifA in vitro in the presence of ADP (31, 93).
Inhibition of open promoter complex formation by NifA in vitro in the presence of ADP, 2-oxoglutarate, and GlnK (60, 63).
Inhibition of open promoter complex formation by NifA in vitro under oxidizing conditions (45, 93).
ND, not determined.